Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600130231Phase 4Completed
Phase 4, randomised trial of remimazolam in None (4 arms), sponsored by Peking University School and Hospital of Stomatology. Primary endpoints: MOAA/S score, Time from administration to loss of consciousness and 6 more. Started Aug 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600130231.